Lisdexamfetamine dimesylate: hydrolysis, pharmacokinetics and duration of therapeutic action in children and adolescents with ADHD

被引:0
|
作者
Haege, A. [1 ]
Dittmann, R. W. [1 ]
Pennick, M. [2 ]
Sorooshian, S. [3 ]
Ermer, J. [4 ]
Adeyi, B. [4 ]
Squires, L. [4 ]
Coghill, D. R. [5 ]
机构
[1] Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Paediat Psychopharmacol, Mannheim, Germany
[2] Shire, Basingstoke, Hants, England
[3] Shire, Eysins, Switzerland
[4] Shire, Wayne, NJ USA
[5] Univ Dundee, Div Neurosci, Dundee, Scotland
关键词
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.7.f.009
引用
收藏
页码:S733 / S734
页数:2
相关论文
共 50 条
  • [21] Growth and sexual maturation in a 2-year, open-label clinical study of lisdexamfetamine dimesylate in children and adolescents with ADHD
    Otero, I. Hernandez
    Banaschewski, T.
    Johnson, M.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Yan, B.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2017, 41 : S130 - S130
  • [22] Does Prior Exposure to Stimulants in Children with ADHD Impact Cardiovascular Parameters From Lisdexamfetamine Dimesylate?
    Wigal, Sharon B.
    Jun, Angela
    Wong, Amanda A.
    Stehli, Annamarie
    Steinberg-Epstein, Robin
    Lerner, Marc A.
    POSTGRADUATE MEDICINE, 2010, 122 (05) : 27 - 34
  • [23] ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years
    Lopez, Frank A.
    Childress, Ann
    Adeyi, Ben
    Dirks, Bryan
    Babcock, Thomas
    Scheckner, Brian
    Lasser, Robert A.
    Shepski, John
    Arnold, Valerie
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (01) : 52 - 61
  • [24] Time-course of treatment-emergent adverse events in a long-term safety study of lisdexamfetamine dimesylate in children and adolescents with ADHD
    Hernandez Otero, I.
    Banaschewski, T.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Caballero, B.
    Geibel, B.
    Yan, B.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2016, 33 : S132 - S132
  • [25] EFFECT OF LISDEXAMFETAMINE DIMESYLATE ON FUNCTIONAL IMPAIRMENT IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Soutullo, C. A.
    Banaschewski, T.
    Lecendreux, M. L.
    Bloomfield, R.
    Hodgkins, P.
    Coghill, D. R.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [26] The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, David
    Banaschewski, Tobias
    Lecendreux, Michel
    Soutullo, Cesar
    Johnson, Mats
    Zuddas, Alessandro
    Anderson, Colleen
    Civil, Richard
    Dauphin, Matthew
    Higgins, Nicholas
    Lyne, Andrew
    Gasior, Maria
    Squires, Liza
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S125 - S125
  • [27] The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Coghill, D. R.
    Banaschewski, T.
    Lecendreux, M.
    Soutullo, C.
    Johnson, M.
    Zuddas, A.
    Anderson, C.
    Civil, R.
    Dauphin, M.
    Lyne, A.
    Gasior, M.
    Squires, L. A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [28] Lisdexamfetamine dimesylate: a Treatment Option for Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Germany and Across Europe
    Haege, A.
    Banaschewski, T.
    Dittmann, R. W.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (12) : 676 - 685
  • [29] Patterns of Lisdexamfetamine Dimesylate Use in Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder in Europe
    Siffel, Csaba
    Page, Matthew
    Maxwell, Tricia
    Thun, Barbara
    Kolb, Nikolaus
    Rosenlund, Mats
    von Bredow, Dorothea
    Keja, Jacco
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (07) : 439 - 447
  • [30] A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE DIMESYLATE IN 4-TO 5-YEAR-OLD CHILDREN WITH ADHD
    Childress, Ann Catherine
    Lloyd, Eric
    Jacobsen, Leslie
    Gunawardhana, Lhanoo
    Findling, Robert L.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2020, 59 (10): : S149 - S149